Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors
C Arter, L Trask, S Ward, S Yeoh, R Bayliss - Journal of Biological Chemistry, 2022 - jbc.org
Protein kinases are key components in cellular signaling pathways as they carry out the
phosphorylation of proteins, primarily on Ser, Thr, and Tyr residues. The catalytic activity of …
phosphorylation of proteins, primarily on Ser, Thr, and Tyr residues. The catalytic activity of …
Cyclin D1, cancer progression, and opportunities in cancer treatment
Mammalian cells encode three D cyclins (D1, D2, and D3) that coordinately function as
allosteric regulators of cyclin-dependent kinase 4 (CDK4) and CDK6 to regulate cell cycle …
allosteric regulators of cyclin-dependent kinase 4 (CDK4) and CDK6 to regulate cell cycle …
Conformational states dynamically populated by a kinase determine its function
INTRODUCTION Protein kinases mediate many cell signaling processes. Central to their
physiological function is the regulation of their binding and enzymatic activities, which is …
physiological function is the regulation of their binding and enzymatic activities, which is …
Structural insights into the functional diversity of the CDK–cyclin family
DJ Wood, JA Endicott - Open biology, 2018 - royalsocietypublishing.org
Since their characterization as conserved modules that regulate progression through the
eukaryotic cell cycle, cyclin-dependent protein kinases (CDKs) in higher eukaryotic cells are …
eukaryotic cell cycle, cyclin-dependent protein kinases (CDKs) in higher eukaryotic cells are …
Activating HER2 mutations in HER2 gene amplification negative breast cancer
Data from 8 breast cancer genome-sequencing projects identified 25 patients with HER2
somatic mutations in cancers lacking HER2 gene amplification. To determine the phenotype …
somatic mutations in cancers lacking HER2 gene amplification. To determine the phenotype …
[HTML][HTML] Allostery in disease and in drug discovery
R Nussinov, CJ Tsai - Cell, 2013 - cell.com
Allostery is largely associated with conformational and functional transitions in individual
proteins. This concept can be extended to consider the impact of conformational …
proteins. This concept can be extended to consider the impact of conformational …
Ten things you should know about protein kinases: IUPHAR R eview 14
D Fabbro, SW Cowan‐Jacob… - British journal of …, 2015 - Wiley Online Library
Many human malignancies are associated with aberrant regulation of protein or lipid
kinases due to mutations, chromosomal rearrangements and/or gene amplification. Protein …
kinases due to mutations, chromosomal rearrangements and/or gene amplification. Protein …
The EGFR family: not so prototypical receptor tyrosine kinases
MA Lemmon, J Schlessinger… - Cold Spring Harbor …, 2014 - cshperspectives.cshlp.org
The epidermal growth factor receptor (EGFR) was among the first receptor tyrosine kinases
(RTKs) for which ligand binding was studied and for which the importance of ligand-induced …
(RTKs) for which ligand binding was studied and for which the importance of ligand-induced …
Structural basis of AMPK regulation by small molecule activators
B **ao, MJ Sanders, D Carmena, NJ Bright… - Nature …, 2013 - nature.com
AMP-activated protein kinase (AMPK) plays a major role in regulating cellular energy
balance by sensing and responding to increases in AMP/ADP concentration relative to ATP …
balance by sensing and responding to increases in AMP/ADP concentration relative to ATP …
Structural insight and development of EGFR tyrosine kinase inhibitors
T Amelia, RE Kartasasmita, T Ohwada, DH Tjahjono - Molecules, 2022 - mdpi.com
Lung cancer has a high prevalence, with a growing number of new cases and mortality
every year. Furthermore, the survival rate of patients with non-small-cell lung carcinoma …
every year. Furthermore, the survival rate of patients with non-small-cell lung carcinoma …